Home > Insider Trading > Filing (0000921895-22-002282)

Filing Details

Accession Number:: 0000921895-22-002282
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-07-25 16:46:21
Reporting Period:: 2022-07-21

Accepted Time:: 2022-07-25 16:46:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1250078	C Derek Schrier	C/O Indaba Capital Management, L.p. One Letterman Dr., Blding D, Suite Dm700 San Francisco CA 94129	No	No	Yes	No
1524362	Indaba Capital Management, L.p.	One Letterman Drive Building D, Suite Dm700 San Francisco CA 94129	No	No	Yes	No
1596505	Ic Gp, Llc	One Letterman Drive, Building D, Suite Dm700 San Francisco CA 94129	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-07-21	179,790	$3.80	5,348,814	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-21	180,210	$3.97	5,529,024	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-21	250,000	$3.58	5,779,024	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-21	290,000	$4.11	6,069,024	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-21	100,000	$4.15	6,169,024	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-22	100,000	$4.22	6,269,024	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-22	103,292	$4.06	6,372,316	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2022-07-22	90,000	$4.43	6,462,316	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	1.75% Convertible Senior Subordinated Notes due 2026	$0.00		2026-02-15	1,282,805	1,282,805	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-02-15	1,282,805	1,282,805	Indirect

Footnotes

This Form 4 is filed jointly by Indaba Capital Management, L.P. (the "Investment Manager"), IC GP, LLC ("IC GP"), and Derek C. Schrier (collectively, the "Reporting Persons"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Securities are held directly by Indaba Capital Fund, L.P. (the "Fund"). Pursuant to an Investment Management Agreement, the Fund and its general partner have delegated all voting and investment power over the securities directly held by the Fund to the Investment Manager. As a result, each of the Investment Manager, IC GP, as the general partner of Investment Manager, and Mr. Schrier, as Managing Member of IC GP, may be deemed to exercise voting and investment power over such securities. The Fund specifically disclaims beneficial ownership of such securities by virtue of its inability to vote or dispose of such securities as a result of such delegation to the Investment Manager.
The Fund directly holds $89,728,000 principal amount of the Issuer's 1.75% Convertible Senior Subordinated Notes due February 15, 2026 (the "Senior Notes"). Subject to conditions described in the indenture governing the Senior Notes, holders of the Senior Notes have the right to convert all or any portion of such Senior Notes into shares of the Issuer's Common Stock at an initial conversion rate of 14.2966 shares of Common Stock per $1,000 principal amount of Senior Notes, subject to adjustment as described in the indenture.
As the Issuer has the option, at its sole discretion, to settle conversions of the Senior Notes in cash, shares of Common Stock or a combination of cash and shares of Common Stock, the Reporting Persons are not deemed to be beneficial owners of any shares of Common Stock underlying the Senior Notes for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as the Reporting Persons do not have the right to acquire such underlying shares of Common Stock.